Cross-cultural adaptation and psychometric validation of the German version of the Central Sensitization Inventory (CSI-Ge)

Completed

• Conditions: R52; M54; F45; R10; Pain, not elsewhere classified; Dorsalgia; Somatoform disorders; Abdominal and pelvic pain

• Registration Number: DRKS00015252
• Lead Sponsor: Klinik für Anästhesiologie, Universitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-24
• Study Completion: 2019-09-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 346

Inclusion Criteria

Chronic pain >= 3 months;
Sufficient physical and cognitive capacity to complete the questionnaires;
Sufficient knowledge of the German language to complete the questionnaires;

Exclusion Criteria

Underlying psychatric disease with pain as predominant symptom (e.g. pure somatoform disorder, severe depression);
Patients at the beginning of a drug therapy of an underlying inflammatory disease;

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychometric properties of the German version of the ‘CSI-Ge’ based on:<br>1) Reliability: Internal consistency (Cronbach’s Alpha) and retest reliability (intraclass correlation coefficient, time span: 2 weeks).<br>2) Validity: structural validity (explorative factor analysis); criterion validity (correlation with pain- and cognition-related questionnaires); Hypothesis-testing (patients with chronic pain achieve significantly higher CSI values compared to healthy control group).

Secondary Outcome Measures

Name	Time	Method
ot applicable.